Movatterモバイル変換

[0]ホーム
URL:

AU6908094A - Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule - Google Patents

Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule

Info

Publication number
AU6908094A
AU6908094AAU69080/94AAU6908094AAU6908094AAU 6908094 AAU6908094 AAU 6908094AAU 69080/94 AAU69080/94 AAU 69080/94AAU 6908094 AAU6908094 AAU 6908094AAU 6908094 AAU6908094 AAU 6908094A
Authority
AU
Australia
Prior art keywords
immunotherapy
alpha
domain
class
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69080/94A
Inventor
Mark L. Tykocinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Publication of AU6908094ApublicationCriticalpatent/AU6908094A/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU69080/94A1993-05-051994-05-03Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility moleculeAbandonedAU6908094A (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US5728793A1993-05-051993-05-05
US0572871993-05-05
PCT/US1994/005065WO1994025610A1 (en)1993-05-051994-05-03Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule

Publications (1)

Publication NumberPublication Date
AU6908094Atrue AU6908094A (en)1994-11-21

Family

ID=22009677

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU69080/94AAbandonedAU6908094A (en)1993-05-051994-05-03Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule

Country Status (2)

CountryLink
AU (1)AU6908094A (en)
WO (1)WO1994025610A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6056952A (en)*1995-08-302000-05-02The United States Of America As Represented By The Department Of Health And Human ServicesSelective elimination of T cells that recognize specific preselected targets
EP1394181A1 (en)*2002-09-022004-03-03Boehringer Ingelheim International GmbHDNA vaccine
US9809654B2 (en)2002-09-272017-11-07Vaccinex, Inc.Targeted CD1d molecules
AU2008219020B2 (en)2007-02-212013-08-22Vaccinex, Inc.Modulation of NKT cell activity with antigen-loaded CDId molecules
CA2748819A1 (en)2009-01-082010-07-15Steven A. PorcelliBacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
US9371352B2 (en)2013-02-082016-06-21Vaccinex, Inc.Modified glycolipids and methods of making and using the same
WO2024192465A1 (en)*2023-03-202024-09-26Garvan Institute Of Medical ResearchVaccines and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0661985B1 (en)*1991-11-081999-07-07The Board Of Trustees Of The Leland Stanford Junior UniversityPeptides capable of binding cd8 molecules on ctl precursors

Also Published As

Publication numberPublication date
WO1994025610A1 (en)1994-11-10

Similar Documents

PublicationPublication DateTitle
AU7333494A (en)Bitetrazoleamine gas generant compositions and methods of use
AU7564694A (en)Erection-inducing methods and compositions
AU7323294A (en)Perfluoroelastomeric compositions and methods
AU4630493A (en)Positionable and repositionable adhesive articles
AU4705697A (en)Systems and methods for the synthesis of organic compounds
AU4886593A (en)Solvent-free organosiloxane composition and its use
AU6096594A (en)Compositions of a hydrofluorocarbon and a hydrocarbon
AU3249793A (en)Compositions and methods for modulating beta -amyloid
AU3978497A (en)Improvements in polymer compositions for chemotherapy and methods of treatment using the same
AU3220593A (en)Soluble mhc molecules and their uses
AU2100695A (en)Immunotherapy of cancer with allogeneic lymphocytes
AU4257193A (en)Turbo compounder
AU6959694A (en)Antineoplastic compositions and methods of use
AU2703197A (en)Revolving structure for display of decorative objects
AU4083997A (en)Gata-6 transcription factor: compositions and methods
AU8123394A (en)Compositions for inhibition of intracellular transcription factors and methods therefor
AU3596893A (en)20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
AU2216497A (en)Novel pyruvate compounds and methods for use thereof
AU6826194A (en)16-hydroxytriptolide composition and method for immunotherapy
AU697416B2 (en)Novel adhesion additives and curable organosiloxane compositions
AU6908094A (en)Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule
AU4329193A (en)Compositions and methods for coating seed
AU8364591A (en)Polyethylene terephthalate compositions and methods of using thereof
AU2762895A (en)Lubricants with molybdenum containing compositions and methods of using the same
AU6274694A (en)Methods and compositions for the inhibition of complement activation
[8]ページ先頭
©2009-2025 Movatter.jp